Potential benefit of higher dose daunorubicin in patients harbouring a FLT3-ITD mutation: Updated results of the AML17 trialNigel H. Russell,Robert Kerrin Hills,Jonathan Kell,J Cavenagh,Lars Kjeldsen,Mary-Frances McMullin,Paul Cahalin,Michael Dennis,Lone S. Friis, Angela Grech,D. Milligan,Richard E. Clark,Alan K. BurnettBRITISH JOURNAL OF HAEMATOLOGY(2016)引用 23|浏览32暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要